HYQVIA is indicated for the treatment of primary immunodeficiency (PI) in adults. HYQVIA is for subcutaneous use only. Safety and efficacy of chronic use of Recombinant Human Hyaluronidase in HYQVIA have not been established in conditions other than PI.

Questions?

Contact your representative.

Get answers to your questions. Talk to a representative about HYQVIA.

Your local Takeda representative is ready to support you and help answer your questions about HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase]. Simply enter your ZIP code below to get in touch with your dedicated TAKEDA representative, or call 1-877-825-3327 to speak with customer service.


*Indicates a required field.